Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
Clinical trial NCT02118896 · COMPLETED
Trial details
- NCT number
- NCT02118896
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-24
- Primary completion
- 2009-10-07
- Enrollment
- 850
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.